𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimizing levodopa pharmacokinetics in Parkinson’s disease: the role of COMT inhibitor

✍ Scribed by F. Stocchi; L. Vacca; P. Grassini; G. Battaglia; M. Onofrj; M. Valente; S. Ruggieri

Publisher
Springer Milan
Year
2003
Tongue
English
Weight
52 KB
Volume
24
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of levodopa and COMT inhibitors
Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients
✍ Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Frad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T

Effect of entacapone, a COMT inhibitor,
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
✍ V. V. Myllylä; K. A. Sotaniemi; A. Illi; K. Suominen; T. Keränen 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari

Pharmacokinetics and effects of levodopa
Pharmacokinetics and effects of levodopa in advanced Parkinson's disease
✍ E. Bredberg; J. Tedroff; S.-M. Aquilonius; L. Paalzow 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 557 KB

Five patients with severe Parkinson's disease were characterized with respect to their pharmacokinetic and pharmacodynamic responses to levodopa given: orally, intravenously (three different infusion rates) and intraduodenally. The best therapeutic infusion rate in the intravenous study was used for